Related Experiment Video

Updated: May 24, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.1K

The transcriptomic architecture of common cancers reflects synthetic lethal interactions

Syed Haider1, Rachel Brough2,3, Santiago Madera2

  • 1Breast Cancer Now Toby Robins Breast Cancer Research Centre, London, UK. Syed.Haider@icr.ac.uk.

Nature Genetics
|March 3, 2025
PubMed

Insights

Cancer cells use transcriptomic buffering to compensate for tumor suppressor gene (TSG) loss. This buffering mechanism, involving synthetic lethal partners, is common across many cancers and offers new therapeutic targets.

Area of Science:

  • Oncology
  • Genetics
  • Systems Biology

Background:

  • Cellular robustness relies on compensatory gene changes to buffer genetic alterations.
  • Synthetic lethality, targeting gene interactions, shows promise in cancer therapy but lacks clinical validation.
  • Understanding buffering mechanisms is crucial for cancer treatment and target identification.

Purpose of the Study:

  • To investigate transcriptomic buffering of tumor suppressor gene (TSG) loss in cancer.
  • To determine if buffering phenomena can be leveraged for synthetic lethality clinical applications.
  • To identify robust synthetic lethal targets based on buffering characteristics.

Main Methods:

  • Integrated analysis of molecular profiling data from over 9,000 cancer samples.
  • Correlated transcriptomic data with results from synthetic lethal screens.
  • Examined buffering in BRCAness cancers and its association with clinical outcomes.

Main Results:

  • Transcriptomic buffering of TSG loss by synthetic lethal partner hyperexpression is a prevalent mechanism in diverse cancers.
  • Buffering is observed in cancers phenocopying TSG loss, like BRCAness.
  • Expression of BRCA1/2 synthetic lethal genes correlates with clinical outcomes in relevant cancers.
  • Genes exhibiting transcriptomic buffering demonstrate more robust synthetic lethal effects.

Conclusions:

  • Transcriptomic buffering helps tumors tolerate TSG loss and shapes cancer's molecular architecture.
  • Buffering mechanisms provide insights for selecting effective synthetic lethal therapeutic targets.
  • This study bridges preclinical synthetic lethality findings with clinical observations.

More Related Videos

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

2.7K
Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.3K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K